Showing 1,277 results

Filters Content type: News, Editors' picks, About HIV Topic: New & experimental HIV treatments

News and information about clinical trials and regulatory approval of new medications to treat HIV.

New & experimental HIV treatments

Drug-level study shows feasibility of long-acting integrase inhibitor cabotegravir

Editor's pick
HIVand hepatitis.com
10 September 2014
Side effects

New Tenofovir Alafenamide Combo Pill Has Less Effect on Kidneys and Bones

Editor's pick
HIVandhepatitis.com
9 September 2014
New & experimental HIV treatments

EU marketing authorization for ViiV Healthcare HIV drug Triumeq

Editor's pick
Pharma Letter
4 September 2014
New & experimental HIV treatments

The Role of Triumeq in HIV Treatment

Editor's pick
The Body
4 September 2014
New & experimental HIV treatments

Aiming For HIV's Weak Spot - The new generation of gp120 entry inhibitors

Editor's pick
C&EN - Chemical and Engineering News
2 September 2014
New & experimental HIV treatments

FDA Approves New Single-Tablet HIV Regimen, Triumeq

Editor's pick
Aidsmeds.com
26 August 2014
The search for a cure

Protein tethers HIV and Ebola to cells

Editor's pick
Futurity
26 August 2014
New & experimental HIV treatments

Theraclone Sciences cuts HIV antibodies deal with Gilead

Editor's pick
San Francisco Business Times (blog)
31 July 2014
New & experimental HIV treatments

The Medicines Patent Pool (MPP) broadens collaboration with Gilead Sciences: Signs licence for Phase III medicine tenofovir alafenamide (TAF)

Editor's pick
Medicines Patent Pool
25 July 2014
The search for a cure

Novel techniques probed in cure research

News
22 July 2014
Hepatitis C treatment

HIV, HCV and TB Pipeline Report

Editor's pick
Treatment Action Group & i-Base
21 July 2014
New & experimental HIV treatments

Therapy with newer, safer antiretrovirals an option for the majority of HIV-positive patients

News
11 July 2014
New & experimental HIV treatments

Triumeq® (dolutegravir/abacavir/lamivudine) single-tablet regimen receives positive CHMP opinion in Europe for the treatment of HIV

Editor's pick
Viiv Healthcare press release
30 June 2014
Treatment guidelines

Dolutegravir in HIV-1 infection: Added benefit in adult patients

Editor's pick
Science Daily
19 June 2014
New & experimental HIV treatments

Glaxo's ViiV Joins J&J's Janssen to Develop Single-Pill HIV Drug

Editor's pick
Bloomberg
13 June 2014
How HIV works

Paper explores new theory on spread of HIV by "popular" cells

Editor's pick
HIV / AIDS News From Medical News Today
11 June 2014
New & experimental HIV treatments

First Patient Enrolled in New Phase 3 Trial Program Investigating a Once-Daily formulation of raltegravir (Isentress)

Editor's pick
Merck
6 June 2014
New & experimental HIV treatments

Dolutegravir in HIV-1 infection: added benefit in adult patients

Editor's pick
IQWIG
23 May 2014
New & experimental HIV treatments

Investigational protease inhibitor TMC310911 highly potent in phase 2 study

News
4 May 2014
Pharmaceutical industry

Gilead Sciences’ New Drug Applications for Cobicistat and Elvitegravir for HIV Therapy Accepted by U.S. FDA

Editor's pick
Gilead press release
22 April 2014
PrEP

Px Wire: Long-Acting Injectables

Editor's pick
AVAC
17 April 2014
New & experimental HIV treatments

Bristol-Myers Squibb Submits New Drug Application to U.S. FDA for a Fixed-Dose Combination Tablet of Atazanavir Sulfate with Cobicistat for People Living with HIV-1

Editor's pick
Bristol-Myers Squibb press release
15 April 2014
The search for a cure

Transplant Drugs May Fight HIV Reservoir

Editor's pick
AIDSMeds
14 April 2014
New & experimental HIV treatments

Nano-sized drug particles to expand HIV treatment further

Editor's pick
Medical Xpress
9 April 2014